Kenvue Inc. (FRA:J4D)

Market Cap	28.06B -27.8%
Revenue (ttm)	12.83B -2.9%
Net Income	1.23B +34.7%
EPS	0.64 +35.3%
Shares Out	n/a
PE Ratio	22.90
Forward PE	16.06
Dividend	0.74 (5.17%)
Ex-Dividend Date	Nov 12, 2025

Volume	100
Average Volume	159
Open	14.31
Previous Close	14.50
Day's Range	14.28 - 14.31
52-Week Range	11.83 - 22.62
Beta	n/a
RSI	45.20
Earnings Date	Feb 6, 2026

About Kenvue

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other...

• Industry: Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2022
• Employees: 22,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: J4D

Financial Performance

In 2024, Kenvue's revenue was $15.46 billion, an increase of 0.07% compared to the previous year's $15.44 billion. Earnings were $1.03 billion, a decrease of -38.10%.

Financial numbers in USD